Background: Cardiac complications are a major cause of postoperative morbidity. The purpose of this study was to
Conclusions: An age of eighty years or more, a history of cardiac disease, and hypertension requiring medication are significant risk factors for developing postoperative cardiac complications following primary unilateral total knee arthroplasty and total hip arthroplasty. Consideration should be given to a preoperative cardiology evaluation and comanagement in the perioperative period for individuals with these risk factors.
Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
B
oth total knee arthroplasty and total hip arthroplasty are effective for reducing costs associated with treating moderate to severe joint arthritis and improving patient function and quality of life 1, 2 . The number of patients undergoing primary total knee arthroplasty and total hip arthroplasty has increased over the last decade, and the frequency of these arthroplasties is anticipated to rise with an aging population 3, 4 . Cardiac events are major postoperative complications following total knee arthroplasty and total hip arthroplasty [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . In fact, serious cardiac complications, including myocardial infarction and cardiac arrest, have been reported to account for 7% to 20% of all major systemic complications following total knee arthroplasty and total hip arthroplasty 5, 16 . With the implementation of performance-based outcome metrics in medicine and penalties associated with high readmission rates after elective total knee arthroplasty and total hip arthroplasty [17] [18] [19] , it is imperative to scrutinize patient-based risk factors and surgical risk factors that may influence the development of cardiac complications. Understanding the risk factors can aid in preoperative counseling of the patient, risk optimization, and enhanced observation in the perioperative period. A detailed investigation of preoperative patient-related risk factors is warranted to provide effective medical care in the perioperative setting and to decrease the need for surgical readmissions following primary total joint arthroplasty 20 . Total knee arthroplasty and total hip arthroplasty are increasingly performed in patients with a greater burden of medical comorbidities, such as diabetes, hypertension, and obesity 15, 21 . However, the effect of individual patient-based risk factors on the development of postoperative cardiac complications remains unknown. If high-risk patients can be identified prior to surgery, targeted interventions may improve patient outcomes and curtail the healthcare costs associated with unplanned hospital readmission and subsequent morbidity.
Previous studies describing adverse postoperative cardiac outcomes following total knee arthroplasty and total hip arthroplasty at tertiary-care facilities may have limited external validity because of sampling from individual centers and from surgeons with extensive experience 5, 7, 9, 11, 12, 16, 22, 23 . The aims of this study were to determine the rates, risk factors, and time of occurrence for cardiac complications at thirty days following surgery, as well as the time of occurrence for deaths, among a large and diverse patient population. The study sample consisted of more than 46,000 patients undergoing either primary unilateral total knee arthroplasty or total hip arthroplasty at any of the numerous medical centers in the U.S. participating in the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP).
Materials and Methods

T
he investigation was approved by our institution's investigational review board. We utilized the NSQIP data set from 2006 to 2011. The NSQIP and its methodology, including data collection, have been described in detail in previous publications 6, 24, 25 . The NSQIP data set has also been utilized for similar prognostic research 6 and has been validated as accurate and reliable for these types of studies. The NSQIP methodology has been carefully examined, with specific attention to case collection, data-set handling, and inter-rater reliability, with disagreement rates on variables approaching 1.6%
25
. Patient information is prospectively entered in the current version of NSQIP from more than 480 hospitals in the U.S., and thirty-day postoperative morbidity and mortality are carefully monitored and recorded 26 . Institutions involved in the NSQIP multispecialty model that capture data on joint arthroplasty cases must collect and submit data on 20% of their orthopaedic surgical caseload. 
The NSQIP data set was queried to identify all patients undergoing primary unilateral total knee arthroplasty and total hip arthroplasty, as designated by Current Procedural Terminology codes 27447 and 27130, respectively. Patients with concomitant codes at the time of index surgery or with bilateral or staged total knee arthroplasty or total hip arthroplasty within thirty days following surgery were excluded. Medical comorbidities, patient demographics, and pertinent laboratory data were documented. Surgical variables, including mode of anesthesia (either general anesthesia or spinal or epidural anesthesia) and total operative time, were recorded as well (see Appendix). The primary outcome measure was the occurrence of a major postoperative cardiac complication, consisting of myocardial infarction or cardiac arrest requiring cardiopulmonary resuscitation (CPR).
Bivariate regression analyses were performed to evaluate the association between itemized patient-based and surgical risk factors and the development of all major cardiac events within thirty days postoperatively. Patient-based risk factors included age (stratified as less than sixty, sixty to sixty-nine, seventy to seventy-nine, and eighty or more years old), sex, body mass index (BMI; <30.0, 30.0 to 39.9, and ‡40.0 kg/m 2 ), American Society of Anesthesiologists (ASA) classification (ASA 1 or 2 compared with 3 or 4), race, medical comorbidities, and revised cardiac risk index composite variable 27 ( ‡3 compared with £2) (see Appendix). Patients were deemed to have a history of cardiac disease if they had one or more of the following: a new diagnosis or exacerbation of chronic congestive heart failure within thirty days before surgery, a history of angina within thirty days before surgery, a history of myocardial infarction within six months before surgery, or a history of any percutaneous cardiac intervention or other major cardiac surgery at any time. Comparisons for operative time were made between the cases that exceeded the mean procedural duration of a total knee arthroplasty or total hip arthroplasty by one standard deviation and those that did not. Multivariable logistic regression was performed for risk factors with a p value of <0.2 after initial bivariate testing to assess the effect of the predictor variables on the risk of developing a major cardiac complication. Risk was calculated with use of odds ratios (ORs) and 95% confidence intervals (CIs) during both bivariate and multivariable regression. We determined a priori that a p value of <0.05 and 95% CI excluding 1.0 after multivariable analysis would be necessary to ascertain a significant independent risk factor. The c-statistic was used to evaluate discriminative capacity, and the Hosmer-Lemeshow goodnessof-fit test was employed to assess the calibration of the final predictive models. 
Source of Funding
Results
T
he NSQIP data set from 2006 to 2011 contains information on 28,682 patients managed with primary unilateral total knee arthroplasty and 17,640 managed with primary unilateral total hip arthroplasty who met the inclusion criteria. The average age of the patients was 67.1 years (standard deviation [SD], 10.2 years) for the total knee arthroplasty group and 65.0 years (SD, 12.4 years) for the total hip arthroplasty group. The percentage of patients with an age of eighty years or more was 11.7% for the total knee arthroplasty group and 13.1% for the total hip arthroplasty group. The majority of the entire total knee arthroplasty and total hip arthroplasty cohort was female (60.5%), white (89.9%), nonsmoking (89.5%), and obese (53.4% with a BMI of ‡30.0) (see Appendix). Nearly 47% of the entire total knee arthroplasty and total hip arthroplasty cohort was designated as ASA class 3 or higher. Among the entire total knee arthroplasty and total hip arthroplasty cohort, medical comorbidities included hypertension requiring medication (64.7%), diabetes mellitus (15.4%), history of cardiac disease (7.1%), and history of transient ischemic attack or cerebrovascular accident (3.6%) (see Appendix). Mean operative time was 96.2 minutes (SD, 38.1 minutes) for total knee arthroplasties and 97.6 minutes (SD, 42.9 minutes) for total hip arthroplasties.
In the thirty-day perioperative period, 167 major cardiac complications in 153 patients (0.33%) within the entire total knee arthroplasty and total hip arthroplasty cohort were recorded (Table I) . There was not a significant difference between the total knee arthroplasty and total hip arthroplasty groups regarding the occurrence of myocardial infarction, cardiac arrest requiring CPR, or development of a major adverse cardiac event. The thirty-day all-cause mortality rates for the cohorts were 0.18% for total knee arthroplasty and 0.35% for total hip arthroplasty. When compared with the total knee arthroplasty group, the total hip arthroplasty group had a significantly increased thirty-day odds ratio of mortality (OR, 1.87; 95% CI, 1.30 to 2.71; p = 0.001). Among the patients who died, twentytwo total knee arthroplasty patients (42%) and seventeen total hip arthroplasty patients (28%) had sustained a major cardiac complication. Bivariate evaluation identified several risk factors for developing a major cardiac complication (Table II) .
Multivariable logistic regression analysis determined significant independent predictors for sustaining a major cardiac complication in both the total knee arthroplasty and total hip arthroplasty groups (Table III) . Significant independent predictors of a major cardiac complication after total knee arthroplasty that maintained ORs exceeding 4.0 were an age of eighty years or more (OR, 27.95; 95% CI, 2.01 to 388.93; p = 0.0016), hypertension requiring medication (OR, 4.74; 95% For the total knee arthroplasty cohort, we had information on the time of occurrence for 97% of adverse cardiac events and 87% of deaths, while time-of-occurrence information was available for 100% of adverse cardiac events and 84% of deaths in the total hip arthroplasty cohort. The occurrence of major adverse cardiac events for the entire total knee arthroplasty and total hip arthroplasty cohort peaked on postoperative day 2, and 63%, 73%, and 79% of all major cardiac complications occurred by postoperative days 3, 5, and 7, respectively. When examining mortality for the entire total knee arthroplasty and total hip arthroplasty cohort, 25%, 35%, and 44% of all perioperative deaths occurred by postoperative days 3, 5, and 7, respectively.
The c-statistic for total knee arthroplasty indicated that 84% of the variation in adverse cardiac events was explained by the final model, while 78% of the variation in all cardiac complications was explained for total hip arthroplasty. Applying our risk factors for adverse cardiac events following total knee arthroplasty and total hip arthroplasty should correctly identify individuals who developed these complications 84% and 78% of the time, respectively. The goodness-of-fit test showed no significant lack of fit for the final regression models (p = 0.88 and p = 0.28 for total knee arthroplasty and total hip arthroplasty, respectively), indicating that both models were well calibrated to the data under consideration. . The increasing number of patients with substantial comorbidities undergoing joint arthroplasty has elevated the potential for adverse events 6, 7, [11] [12] [13] [14] [15] [16] 19 . Systemic medical complications, particularly those with cardiovascular involvement, increase the risk for unplanned hospital readmission, death, and other postoperative morbidity [15] [16] [17] 20, 21, 24 . Recently, Medicare and other third-party payers have targeted hospital readmission as a quality measure, and its occurrence may result in reduced reimbursement 19, 20 . In light of these developments, it is necessary for providers and institutions to identify patientspecific and surgical risk factors that can increase the chance of a perioperative cardiac complication. Understanding these risk factors can aid in preoperative counseling of the patient, risk optimization, and enhanced observation in the perioperative period. The composition of the population under study-with 12% eighty years old or older, 15% diabetic, and 7% with a history of cardiac disease-is similar to the composition in several other analyses [28] [29] [30] . Additionally, the rates of cardiac complications-including myocardial infarction (0.25%), cardiac arrest requiring CPR (0.11%), and all major cardiac complications (0.33%)-in the current work were comparable with those in previous large-scale investigations 10, 31, 32 .
We believe that the current study is one of the most thorough investigations to date, elucidating patient-based and surgical risk factors for the development of cardiac complications following primary unilateral total knee arthroplasty and total hip arthroplasty. The level and amount of detail in the NSQIP-based variables (including medical comorbidities, body mass index, pertinent laboratory data, and surgical variables) are not present in other administrative databases or registries, which may limit comparison with prior studies. An age of eighty years or more was the most significant risk factor when examining both the primary unilateral total knee arthroplasty and the total hip arthroplasty cohorts. Mantilla et al. 23 maintained that elderly patients were at an elevated risk of postoperative myocardial infarction or death, although their study lacked a rigorous definition of preoperative cardiac history.
Following an age of eighty years of more, the presence of cardiac disease and hypertension requiring medication were the next most important predictors for developing a major cardiac complication when examining both the total knee arthroplasty and the total hip arthroplasty cohorts in the present work (Table III) . The cardiac risk index 33 and subsequent revised cardiac risk index 27 have been used as tools for clinical risk stratification and prediction of cardiovascular complications for major procedures not involving the heart. Lee et al. 27 , utilizing the revised cardiac risk index, previously identified that high-risk surgery; a history of ischemic heart disease, congestive heart failure, or cerebrovascular disease; preoperative treatment with insulin; and preoperative serum creatinine of >2.0 mg/dL were important predictors for sustaining a cardiac complication in patients undergoing major nonemergent vascular surgery. These risk factors are in stark contrast to those found in the current study, in which an age of eighty years or more and hypertension requiring medication were two of the most important predictors for sustaining a postoperative cardiac event. Additionally, our analysis failed to identify a history of ischemic heart disease and a history of congestive heart failure as independent predictors of postoperative cardiac complications. In assessing the performance of the revised cardiac risk index in predicting postoperative cardiac complications, the number of patients exhibiting high scores on this index may have been too small to adequately power the study and thus may subject this analysis to type-II error within this variable.
Existing data concerning the time of occurrence of cardiac complications and death following total knee arthroplasty and total hip arthroplasty procedures are limited. There has been an increased emphasis on shorter hospital stays following elective total joint arthroplasty procedures, with the duration of hospital stays steadily decreasing 15 . In the current study, we found that 63% of total knee arthroplasty patients and 77% of total hip arthroplasty patients who had an adverse cardiac event experienced it within three days following the procedure, similar to the findings in previous reports 12 . This corroborates the finding that delaying discharge until postoperative day 3 will capture up to 83% of possible cardiac events in the hospital 9, 11 . Therefore, in addition to careful observation, consideration should be given to observing total knee arthroplasty and total hip arthroplasty patients with multiple risk factors for sustaining a myocardial infarction or cardiac arrest in the hospital for at least three days postoperatively.
The current study has several limitations. First, potential confounders such as surgeon experience, hospital quality and volume 34 , facility location, and payer mix are not included in the NSQIP data set. Second, patients with missing statistical data could not be included in the multivariable analysis, and the low rate of cardiac events may have resulted in a model that was overfit, which increases the possibility that some significant findings may have occurred solely because of chance. Lastly, the dependence on data from a registry that requires collection and submission of only 20% of the entire orthopaedic surgical caseload may also create the potential for sample bias or underreporting that might also adversely impact our findings. However, the NSQIP employs a sampling strategy and a comprehensive oversight program with strict training and auditing procedures designed to mitigate the potential for inaccurate reporting 25, 26 . We believe that this investigation is of ample magnitude and scope to reliably identify patient-based and surgical risk factors that could be used to develop prognostications for postoperative cardiac complications following primary unilateral total knee arthroplasty and total hip arthroplasty. An age of eighty years or more, a history of cardiac disease, and hypertension requiring medication were the only significant predictors for the development of postoperative cardiac complications that remained following multivariable analysis in both the total knee arthroplasty and the total hip arthroplasty groups. This finding indicates that patients with one or more of the identified risk factors who are undergoing primary unilateral total knee arthroplasty or total hip arthroplasty should be considered for preoperative cardiology evaluation and comanagement in the perioperative period. Additionally, a study designed to determine the cost effectiveness of delaying the discharge of patients with one or more of these risk factors would be beneficial, as more than two-thirds of all adverse cardiac events occurred within the first three days following surgery.
